Indication
Hereditary factor XIII a subunit deficiency
Hereditary factor XIII A-subunit deficiency is an extremely rare, life-threatening autosomal recessive bleeding disorder affecting the hematologic system, caused by mutations in the *F13A1* gene. Read more about Hereditary factor XIII a subunit deficiency
1 drugs 1 manufacturers
Drugs that treat it
Common Hereditary factor XIII a subunit deficiency therapies.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonHereditary factor XIII A-subunit deficiency is an extremely rare, life-threatening autosomal recessive bleeding disorder affecting the hematologic system, caused by mutations in the *F13A1* gene.
This genetic defect results in the absence or dysfunction of the catalytic A subunit of coagulation factor XIII, impairing the cross-linking and stabilization of fibrin polymers during clot formation.
Consequently, blood clots form normally but remain unstable and prone to premature breakdown, leading to severe hemorrhagic manifestations such as delayed umbilical cord bleeding in neonates, spontaneous intracranial hemorrhage, intramuscular hematomas, defective wound healing, and recurrent pregnancy loss.
- bleeding.org
Hereditary factor XIII A-subunit deficiency is an extremely rare, life-threatening autosomal recessive bleeding disorder affecting the hematologic system, caused by mutations in the *F13A1* gene
- scholasticahq.com
Hereditary factor XIII A-subunit deficiency is an extremely rare, life-threatening autosomal recessive bleeding disorder affecting the hematologic system, caused by mutations in the *F13A1* gene This genetic defect results in the absence or dysfunction of the catalytic A subunit of coagulation factor XIII, impairing the cross-linking and stabilization of fibrin polymers during clot formation
- nih.gov
Hereditary factor XIII A-subunit deficiency is an extremely rare, life-threatening autosomal recessive bleeding disorder affecting the hematologic system, caused by mutations in the *F13A1* gene
- nih.gov
This genetic defect results in the absence or dysfunction of the catalytic A subunit of coagulation factor XIII, impairing the cross-linking and stabilization of fibrin polymers during clot formation Consequently, blood clots form normally but remain unstable and prone to premature breakdown, leading to severe hemorrhagic manifestations such as delayed umbilical cord bleeding in neonates, spontaneous intracranial hemorrhage, intramuscular hematomas, defective wound healing, and recurrent pregnan...
- nih.gov
This genetic defect results in the absence or dysfunction of the catalytic A subunit of coagulation factor XIII, impairing the cross-linking and stabilization of fibrin polymers during clot formation
- rarediseases.org
Consequently, blood clots form normally but remain unstable and prone to premature breakdown, leading to severe hemorrhagic manifestations such as delayed umbilical cord bleeding in neonates, spontaneous intracranial hemorrhage, intramuscular hematomas, defective wound healing, and recurrent pregnancy loss
- medicover-genetics.com
Consequently, blood clots form normally but remain unstable and prone to premature breakdown, leading to severe hemorrhagic manifestations such as delayed umbilical cord bleeding in neonates, spontaneous intracranial hemorrhage, intramuscular hematomas, defective wound healing, and recurrent pregnancy loss
- nih.gov
Consequently, blood clots form normally but remain unstable and prone to premature breakdown, leading to severe hemorrhagic manifestations such as delayed umbilical cord bleeding in neonates, spontaneous intracranial hemorrhage, intramuscular hematomas, defective wound healing, and recurrent pregnancy loss
Personalize your experience
Follow Hereditary factor XIII a subunit deficiency and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.